IPSC vs VTR · rev $6.6M vs P/E 149, rev $4.92B
Century Therapeutics Inc (IPSC) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported VTR revenue for 2024-12-31 was $4.92B. Net income was $88.4M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
IPSC currently screens at market cap $47.8M. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the IPSC and VTR stock pages for the full models.
Not investment advice.